Metabolism of debrisoquine and susceptibility to breast cancer (Q67919493)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854978 AND SRC:MED&resulttype=core&format=json

19 September 2019

title

Metabolism of debrisoquine and susceptibility to breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854978 AND SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

10 December 2022

5

D Schmähl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854978 AND SRC:MED&resulttype=core&format=json

19 September 2019

author name string

J. Huober

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1854978

10 December 2022

B. Bertram

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1854978

10 December 2022

E. Petru

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1854978

10 December 2022

M. Kaufmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1854978

10 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1854978

10 December 2022

publication date

1 March 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854978 AND SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

http://link.springer.com/content/pdf/10.1007/BF01975442.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01975442/fulltext.html

10 December 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01975442

10 December 2022

1 reference

Breast Cancer Research and Treatment

10 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854978 AND SRC:MED&resulttype=core&format=json

19 September 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854978 AND SRC:MED&resulttype=core&format=json

19 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854978 AND SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

43-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1854978 AND SRC:MED&resulttype=core&format=json

Lung cancer and the debrisoquine metabolic phenotype

19 September 2019

cites work

1 reference

12 December 2020

Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22.

1 reference

12 December 2020

Premenopausal and Postmenopausal Breast Cancer: One Disease or Two?

1 reference

12 December 2020

Dietary factors and the risk of breast cancer

1 reference

12 December 2020

Enzymatic activation of chemicals to toxic metabolites.

1 reference

12 December 2020

Cellular transforming genes and oncogenesis

1 reference

12 December 2020

Polymorphic hydroxylation of debrisoquine

1 reference

12 December 2020

Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical Significance

1 reference

12 December 2020

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

1 reference

12 December 2020

Etiology of Human Breast Cancer: A Review2

1 reference

12 December 2020

Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.

1 reference

12 December 2020

The endocrinology of breast cancer

1 reference

12 December 2020

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

12 December 2020

Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.

1 reference

12 December 2020

Polymorphism of human cytochrome P-450.

1 reference

12 December 2020

Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors

1 reference

12 December 2020

Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man

1 reference

12 December 2020

Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture.

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Genetically determined debrisoquine oxidation capacity in bladder cancer.

1 reference

12 December 2020

Debrisoquine oxidation phenotype and susceptibility to lung cancer

1 reference

12 December 2020

Determination of debrisoquine and its 4-hydroxy metabolite in urine by high-performance liquid chromatography

1 reference

12 December 2020

P450 genes: evolution, regulation, and relationship to human cancer and pharmacogenetics

1 reference

12 December 2020

The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene

1 reference

12 December 2020

Debrisoquine metabolism and genetic predisposition to lung cancer

1 reference

12 December 2020

Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration.

1 reference

12 December 2020

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms

1 reference

12 December 2020

Genetic predisposition to breast cancer

3

1 reference

Journal of the National Cancer Institute

10 December 2022

6

54

829

NL Petrakis

1975

1 reference

Biochimica et Biophysica Acta

10 December 2022

36

738

9

GM Cooper

1984

1 reference